Amundi Guardant Health, Inc. Transaction History

Amundi

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$25.8 - $39.97 $940,410 - $1.46 Million	-36,450 Reduced 98.21%	666 $19,000
Q2 2023 Aug 14, 2023	SELL	$20.94 - $38.01 $335,207 - $608,464	-16,008 Reduced 30.13%	37,116 $1.33 Million
Q1 2023 May 15, 2023	BUY	$22.92 - $33.76 $67,063 - $98,781	2,926 Added 5.83%	53,124 $1.25 Million
Q4 2022 Feb 14, 2023	BUY	$25.44 - $59.78 $191,486 - $449,964	7,527 Added 17.64%	50,198 $1.37 Million
Q3 2022 Nov 14, 2022	SELL	$43.66 - $61.0 $6.94 Million - $9.7 Million	-159,053 Reduced 78.85%	42,671 $2.55 Million
Q2 2022 Aug 15, 2022	SELL	$28.82 - $77.35 $454,981 - $1.22 Million	-15,787 Reduced 7.26%	201,724 $9.69 Million
Q1 2022 May 16, 2022	SELL	$48.25 - $100.49 $6.47 Million - $13.5 Million	-134,007 Reduced 38.12%	217,511 $16 Million
Q4 2021 Feb 14, 2022	BUY	$88.71 - $120.43 $19 Million - $25.7 Million	213,694 Added 155.05%	351,518 $27.7 Million
Q3 2021 Nov 15, 2021	BUY	$98.77 - $132.17 $13.6 Million - $18.2 Million	137,824 New	137,824 $17.2 Million

324

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.64B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Amundi, based on Form 13F filings with the SEC.

Stay updated on Amundi with notifications on news.